3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neutropenia
5
Breast Neoplasms
5
Febrile Neutropenia
3
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Malignant Solid Tumors
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breastcancer
1
Breast Cancer Female
1
Interventions
Granulocyte Colony-Stimulating Factor
7
Filgrastim
7
Etoposide
7
Temozolomide
6
Cyclophosphamide
6
Carboplatin
6
Vincristine
5
Methotrexate
4
Cisplatin
4
tazemetostat
3
etoposide phosphate
3
Thiotepa
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Leucovorin
3
ribociclib
2
abemaciclib
2
Vorinostat
2
Sirolimus
2
Radiotherapy
2
Melphalan
2
Irinotecan
2
Busulfan
2
veliparib
1
trametinib
1
sonidegib
1
sargramostim
1
reolysin
1
pegylated granulocyte colony-stimulating factor
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Rhabdoid Tumor
×
pegylated granulocyte colony-stimulating factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled